Skip to content
Clinical Trials – home
CzechiaBack to Czechia

Clinical trials in Marianske Lazne

12 clinical trials in Marianske Lazne, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.

CzechiaOur site in CzechiaKlinickeTesty.cz(opens in a new tab)
Marianske Lazne at a glance
12
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

12 trials in Marianske Lazne

Open in trial search
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB

Cardiac failure

Recruiting
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Pelacarsen
  • Sponsor:Novartis Pharma AG
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:CzechiaCzechia
  • Participants:18–64 years
  • Sponsor:Novo Nordisk A/S

Arteriosclerosis

Not recruiting
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Pelacarsen
  • Sponsor:Novartis Pharma AG

Arteriosclerosis

Not recruiting
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Novartis Pharma AG
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Obicetrapib
  • Sponsor:NewAmsterdam Pharma B.V.

Arteriosclerosis

Not recruiting
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Inclisiran
  • Sponsor:Novartis Pharma AG
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.

Other cities in Czechia

The busiest research cities in the country

All 158 cities in Czechia

Clinical research in Marianske Lazne

What the registry says about research in the country

01 Cardiovascular Disease Prevention

Groundbreaking research focusing on preventive cardiology, particularly studying new approaches to reduce the risk of major cardiovascular events in high-risk patients.

  • Primary prevention strategies
  • Risk reduction therapies
  • Cardiovascular mortality prevention

Multiple trials evaluating innovative treatments to protect against heart disease complications.

02 Heart Failure Management

Studies examining combination therapies for heart failure, including investigations of novel drug combinations to improve patient outcomes and reduce hospitalizations.

  • Combination therapy approaches
  • Disease progression management
  • Treatment optimization

Research aimed at enhancing current treatment protocols for heart failure patients.

03 Atherosclerosis Research

Innovative trials targeting atherosclerotic cardiovascular disease, exploring new therapeutic options for patients with established vascular conditions.

  • Lipid-modifying treatments
  • Vascular disease management
  • Arterial health improvement

Advanced studies focusing on reducing major adverse cardiovascular events.

04 Cardiac Rhythm Disorders

Clinical investigations comparing treatment options for atrial fibrillation, with emphasis on safety and efficacy of new therapeutic approaches.

  • Anticoagulation therapies
  • Heart rhythm management
  • Bleeding risk assessment

Evaluating novel treatments for irregular heart rhythms and related complications.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.